|
|
|
Insider
Information: |
Sanofi-Aventis |
Relationship: |
10% Owner |
City: |
Paris |
State: |
I0 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
75,668,031 |
|
Indirect Shares
|
26,048,661 |
|
|
Direct
Value |
$2,826,957,638 |
|
|
Indirect Value
|
$1,869,919,512 |
|
|
Total
Shares |
101,716,692 |
|
|
Total
Value |
$4,696,877,150 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
5
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
3
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-17.8%
|
-3.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2014-02-04 |
5,053,779 |
Premium* |
|
Humanigen Inc |
HGEN |
Former 10% owner |
2013-01-31 |
0 |
2013-01-31 |
579,030 |
Premium* |
|
Glycomimetics Inc |
GLYC |
10% Owner |
|
0 |
2013-11-06 |
1,193,625 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
|
2020-05-29 |
0 |
2020-06-09 |
279,766 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2017-05-31 |
10,554,134 |
Premium* |
|
Scynexis Inc |
SCYX |
10% Owner |
|
0 |
2014-05-07 |
1,677,057 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
Former 10% owner |
2015-11-10 |
0 |
2015-11-16 |
2,477,941 |
Premium* |
|
Fulcrum Therapeutics, Inc. |
FULC |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
558,035 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
520,125 |
Premium* |
|
Icosavax, Inc. |
ICVX |
10% Owner |
2021-08-02 |
0 |
2021-08-02 |
3,155,169 |
Premium* |
|
Translate Bio, Inc. |
TBIO |
10% Owner |
2021-09-14 |
75,668,031 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-12 |
4 |
B |
$325.40 |
$73,964,412 |
I/I |
220,995 |
17,994,836 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-20 |
4 |
B |
$325.94 |
$19,033,511 |
I/I |
57,957 |
18,178,250 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-19 |
4 |
B |
$326.44 |
$3,195,651 |
I/I |
9,746 |
18,120,293 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-14 |
4 |
B |
$326.77 |
$18,251,215 |
I/I |
55,583 |
18,050,419 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-07 |
4 |
B |
$327.77 |
$80,405,733 |
I/I |
241,818 |
17,393,309 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-03 |
4 |
B |
$328.00 |
$85,070,118 |
I/I |
251,594 |
17,001,214 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-17 |
4 |
B |
$328.32 |
$19,755,234 |
I/I |
60,128 |
18,110,547 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-10-16 |
4 |
AB |
$328.47 |
$40,955,057 |
I/I |
122,127 |
22,657,685 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-11 |
4 |
B |
$328.82 |
$60,043,336 |
I/I |
180,710 |
17,773,841 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-06 |
4 |
B |
$338.64 |
$27,305,546 |
I/I |
80,404 |
17,081,618 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-09-15 |
4 |
B |
$340.88 |
$27,802,187 |
I/I |
80,824 |
22,345,473 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-09-12 |
4 |
B |
$345.07 |
$20,737,541 |
I/I |
59,808 |
22,264,649 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-09-16 |
4 |
B |
$347.78 |
$11,077,574 |
I/I |
31,717 |
22,377,190 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2016-06-14 |
4 |
B |
$361.44 |
$23,552,859 |
I/I |
64,731 |
23,418,396 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2017-01-11 |
4 |
B |
$362.47 |
$32,274,872 |
I/I |
87,298 |
23,505,694 |
2.64 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-12-23 |
4 |
B |
$384.43 |
$67,251,142 |
I/I |
171,457 |
22,829,142 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2016-02-16 |
4 |
B |
$387.43 |
$31,751,182 |
I/I |
81,157 |
23,273,665 |
0.01 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2016-02-17 |
4 |
B |
$390.14 |
$31,496,728 |
I/I |
80,000 |
23,353,665 |
0.01 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-12-24 |
4 |
B |
$392.72 |
$11,964,501 |
I/I |
30,002 |
22,859,144 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2018-09-06 |
4 |
S |
$406.68 |
$42,519,249 |
I/I |
(104,552) |
23,654,384 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2019-03-08 |
4 |
S |
$412.17 |
$54,041,316 |
D/D |
(131,115) |
20,723,717 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2015-10-06 |
4 |
B |
$449.14 |
$37,024,197 |
I/I |
80,538 |
23,097,530 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2016-01-12 |
4 |
B |
$453.89 |
$39,034,660 |
I/I |
83,938 |
23,192,508 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2017-06-02 |
4 |
B |
$466.38 |
$65,055,558 |
I/I |
136,050 |
23,641,744 |
2.64 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2015-10-06 |
4 |
B |
$470.41 |
$5,214,519 |
I/I |
11,040 |
23,108,570 |
1.5 |
- |
|
85 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|